Performance analysis of Aptevo Therapeutics (APVO)
Annual Return
Over the past 3 years, APVO has had an average annual return of -96.23%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, APVO has had an average annual return of -89.14%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, APVO has had an average annual return of -66.59%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Jul 20, 2016, APVO has had an average annual return of -66.60%, underperforming the benchmark SPY, which returned +14.91% annual.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -93.75% | -92.27% | -70.55% | -78.51% | +299.51% | -48.43% | -70.04% | +73.77% | -69.50% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -6.25% | -0% | -33.33% | -90.00% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | -93.75% |
| 2023 | -0.97% | -7.80% | -3.70% | -6.04% | -18.71% | -6.47% | -28.46% | -58.06% | -25.64% | -13.79% | -32.00% | -5.88% | -92.27% |
| 2022 | -25.89% | -1.34% | +1.95% | -27.48% | +7.63% | -21.76% | +10% | -10.23% | -14.24% | -0.37% | +3.33% | -25.81% | -70.55% |
| 2021 | -8.59% | -2.34% | -6.71% | -12.48% | -2.22% | -14.11% | -16.33% | -4.36% | -13.97% | -1.31% | -34.68% | -20.92% | -78.51% |
| 2020 | -9.89% | -27.10% | -38.66% | +35.15% | +14.13% | +46.56% | +0.54% | -6.67% | -3.00% | -15.02% | +576.60% | -16.19% | +299.51% |
| 2019 | +25.94% | -5.00% | -40.79% | -19.11% | -0.44% | +22.41% | +0.36% | -22.19% | -15.13% | -5.31% | +16.81% | +0.74% | -48.43% |
| 2018 | -20.04% | -6.49% | +3.15% | +35.47% | +25.50% | -10.26% | -15.42% | +30.81% | -7.97% | -33.65% | -31.76% | -44.77% | -70.04% |
| 2017 | -18.43% | +0.48% | +3% | -2.91% | +5.52% | -1.90% | -11.13% | -27.74% | +72.26% | +24.66% | +5.41% | +40.88% | +73.77% |
Drawdown analysis of Aptevo Therapeutics (APVO)
The maximum drawdown for the APVO was -99.99%, occurring on Apr 17, 2024. This drawdown has not yet recovered.
The current APVO drawdown is -99.99%.
Since Jul 20, 2016 APVO has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Jul 20, 2016 | 1948 | Apr 17, 2024 | Ongoing | Ongoing | Ongoing |